University of Utah Health Adult Congenital Heart Disease

Topics

• Heart Failure Treatment and Management 75
• Mechanical Circulatory Support Devices 48
• Congenital Heart Disease Studies 34
• Cardiac pacing and defibrillation studies 28
• Vascular Anomalies and Treatments 27
• Cardiovascular Function and Risk Factors 21
• Vascular Malformations Diagnosis and Treatment 20
• Cardiac Valve Diseases and Treatments 19
• Transplantation: Methods and Outcomes 19
• Cardiac Arrhythmias and Treatments 17
• Diabetes Treatment and Management 15
• Atrial Fibrillation Management and Outcomes 12

Most cited

1. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

   Circulation · 2022 · 4,889 citations · James Fang

2. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

   Journal of the American College of Cardiology · 2022 · 2,444 citations · James Fang

3. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.

   The New England journal of medicine · 2022 · 2,297 citations · James Fang

4. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

   Circulation · 2022 · 873 citations · James Fang

5. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

   Journal of the American College of Cardiology · 2022 · 834 citations · James Fang

6. Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.

   The New England journal of medicine · 2021 · 487 citations ·